REQUEST A DEMO
Total
USD $0.00
Search more companies

Med Gen-Sol Kft (Hungary)

Main Activities: Other Management Consulting Services
Full name: Med Gen-Sol Kft. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Med Gen-Sol Kft is a healthcare company specializing in developing tests for cancer patients, including smartphone applications. The company offers test options that allow for further refinement of pathological diagnoses and provide personalized treatment information. Founded with the goal of optimizing treatments and improving the quality of life for patients, Med Gen-Sol Kft is committed to providing solutions in the healthcare industry.

Headquarters
Hovirag ut 2. A. ep. 2. em. 5.
Budapest; Budapest; Postal Code: 1121

Contact Details: Purchase the Med Gen-Sol Kft report to view the information.

Website: http://www.genomic-solution.hu

Basic Information
Total Employees:
Purchase the Med Gen-Sol Kft report to view the information.
Outstanding Shares:
Purchase the Med Gen-Sol Kft report to view the information.
Registered Capital:
Purchase the Med Gen-Sol Kft report to view the information.
Financial Auditors:
Purchase the Med Gen-Sol Kft report to view the information.
Incorporation Date:
May 03, 2010
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Med Gen-Sol Kft report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
25.61%
Total operating revenue
18.42%
Operating profit (EBIT)
219.76%
EBITDA
148.2%
Net Profit (Loss) for the Period
N/A
Total assets
42.68%
Total equity
N/A
Operating Profit Margin (ROS)
3.96%
Net Profit Margin
N/A
Return on Equity (ROE)
-111.01%
Quick Ratio
0.32%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?